MyJournals Home  

RSS FeedsA multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients (British Journal of Cancer)

 
 

13 february 2019 10:00:19

 
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients (British Journal of Cancer)
 






Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
36 viewsCategory: Oncology
 
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer (British Journal of Cancer)
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma (British Journal of Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn